Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−26.2710 USD
−14.46 M USD
60.00 K USD
564.47 K
About Yield10 Bioscience, Inc.
Sector
CEO
Oliver P. Peoples
Headquarters
Woburn
Website
Founded
1992
FIGI
BBG000J1XWG2
Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of YTEN is 0.4200 USD — it has decreased by −9.68% in the past 24 hours. Watch Yield10 Bioscience, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Yield10 Bioscience, Inc. stocks are traded under the ticker YTEN.
YTEN stock has fallen by −22.25% compared to the previous week, the month change is a −51.16% fall, over the last year Yield10 Bioscience, Inc. has showed a −99.74% decrease.
YTEN reached its all-time high on Oct 30, 2007 with the price of 1,645,279,285.3584 USD, and its all-time low was 0.3841 USD and was reached on Nov 12, 2024. View more price dynamics on YTEN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
YTEN stock is 24.39% volatile and has beta coefficient of 0.10. Track Yield10 Bioscience, Inc. stock price on the chart and check out the list of the most volatile stocks — is Yield10 Bioscience, Inc. there?
Today Yield10 Bioscience, Inc. has the market capitalization of 290.92 K, it has decreased by −40.14% over the last week.
Yes, you can track Yield10 Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
Yield10 Bioscience, Inc. is going to release the next earnings report on Nov 18, 2024. Keep track of upcoming events with our Earnings Calendar.
YTEN net income for the last quarter is −3.24 M USD, while the quarter before that showed −2.47 M USD of net income which accounts for −30.99% change. Track more Yield10 Bioscience, Inc. financial stats to get the full picture.
No, YTEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 18, 2024, the company has 29.00 employees. See our rating of the largest employees — is Yield10 Bioscience, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Yield10 Bioscience, Inc. EBITDA is −12.32 M USD, and current EBITDA margin is −23.55 K%. See more stats in Yield10 Bioscience, Inc. financial statements.
Like other stocks, YTEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Yield10 Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Yield10 Bioscience, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Yield10 Bioscience, Inc. stock shows the sell signal. See more of Yield10 Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.